|
1
|
D'Amico E, Chisari CG, Arena S, Zanghì A,
Toscano S, Lo Fermo S, Maimone D, Castaing M, Sciacca S, Zappia M,
et al: Cancer risk and multiple sclerosis: Evidence from a large
italian cohort. Front Neurol. 10(337)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Etemadifar M, Jahanbani-Ardakani H,
Ghaffari S, Fereidan-Esfahani M, Changaei H, Aghadoost N, Jahanbani
Ardakani A and Moradkhani N: Cancer risk among patients with
multiple sclerosis: A cohort study in Isfahan, Iran. Caspian J
Intern Med. 8:172–177. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gaindh D, Kavak KS, Teter B, Vaughn CB,
Cookfair D, Hahn T and Weinstock-Guttman B: New York State Multiple
Sclerosis Consortium. Decreased risk of cancer in multiple
sclerosis patients and analysis of the effect of disease modifying
therapies on cancer risk. J Neurol Sci. 370:13–17. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Grytten N, Myhr KM, Celius EG, Benjaminsen
E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T and
Torkildsen Ø: Risk of cancer among multiple sclerosis patients,
siblings, and population controls: A prospective cohort study. Mult
Scler: Oct 1, 2019 (Epub ahead of print). doi:
10.1177/1352458519877244.
|
|
5
|
Moisset X, Perié M, Pereira B, Dumont E,
Lebrun-Frenay C, Lesage FX, Dutheil F, Taithe F and Clavelou P:
Decreased prevalence of cancer in patients with multiple sclerosis:
A case-control study. PLoS One. 12(e0188120)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lebrun C and Rocher F: Cancer risk in
patients with multiple sclerosis: Potential impact of
disease-modifying drugs. CNS Drugs. 32:939–949. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ragonese P, Aridon P, Vazzoler G, Mazzola
MA, Lo Re V, Lo Re M, Realmuto S, Alessi S, D'Amelio M, Savettieri
G, et al: Association between multiple sclerosis, cancer risk, and
immunosuppressant treatment: A cohort study. BMC Neurol.
17(155)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Grimm D: Current knowledge in thyroid
cancer-from bench to bedside. Int J Mol Sci.
18(1529)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thomas VP and George R: Collision tumors
of the thyroid: Review of literature and report of a case of
papillary-follicular collision tumor. Thyroid Res Pract. 15:60–64.
2018.
|
|
10
|
Lloyd RV, Osamura RY, Kloppel G and Rosai
J: WHO Classification of Tumours of Endocrine Organs. 4th edition.
IARC, Lyon, pp65-114, 2017.
|
|
11
|
Rosai J, BeLellis RA, Carcangiu ML, Frable
WJ and Tallini G: Tumors of the thyroid and parathyroid glands. In:
AFIP Atlas of Tumor Pathology. ARP, Maryland, pp103-130, 2014.
|
|
12
|
Park YM, Kim JR, Oh KH, Cho JG, Baek SK,
Kwon SY, Jung KY and Woo JS: Comparison of functional outcomes
after total thyroidectomy and completion thyroidectomy:
Hypoparathyroidism and postoperative complications. Auris Nasus
Larynx. 46:101–105. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ritter K, Elfenbein D, Schneider DF, Chen
H and Sippel RS: Hypoparathyroidism after total thyroidectomy:
Incidence and resolution. J Surg Res. 197:348–353. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Teshima M, Otsuki N, Morita N, Furukawa T,
Shinomiya H, Shinomiya H and Nibu KI: Postoperative
hypoparathyroidism after total thyroidectomy for thyroid cancer.
Auris Nasus Larynx. 45:1233–1238. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Christoforides C, Papandrikos I, Polyzois
G, Roukounakis N, Dionigi G and Vamvakidis K: Two-stage
thyroidectomy in the era of intraoperative neuromonitoring. Gland
Surg. 6:453–463. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nayak SP, Sadhoo A, Gangadhara B, Reddy S,
Khan A, Munisiddaiah D and Ramakrishnan A: Robotic-assisted breast-
axillo insufflation thyroidectomy (RABIT): A retrospective case
series of thyroid carcinoma. Int J Clin Oncol. 25:439–445.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Milosevic Z, Tanic N, Bankovic J,
Stankovic T, Buta M, Lavrnic D, Milovanovic Z, Pupic G, Stojkovic
S, Milinkovic V, et al: Genetic alterations in quadruple
malignancies of a patient with multiple sclerosis: Their role in
malignancy development and response to therapy. Int J Clin Exp
Pathol. 7:1826–1833. 2014.PubMed/NCBI
|
|
18
|
Roshini AP, Ramesh R and Rajalakshmi T:
HATRICK-synchronous triple primary tumors of thyroid. Indian J Surg
Oncol. 9:592–594. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kingwell E, Evans C, Zhu F, Oger J,
Hashimoto S and Tremlett H: Assessment of cancer risk with
β-interferon treatment for multiple sclerosis. J Neurol Neurosurg
Psychiatry. 85:1096–1102. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Young LS, Yap LF and Murray PG:
Epstein-Barr virus: More than 50 years old and still providing
surprises. Nat Rev Cancer. 16:789–802. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fugl A and Andersen CL: Epstein-Barr virus
and its association with disease - a review of relevance to general
practice. BMC Fam Pract. 20(62)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pyzik A, Grywalska E, Matyjaszek-Matuszek
B, Ludian J, Kiszczak-Bochyńska E, Smoleń A, Roliński J and Pyzik
D: Does the Epstein-Barr virus play a role in the pathogenesis of
Graves' disease? Int J Mol Sci. 20(3145)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bychkov A and Keelawat S: Epstein-Barr
virus and thyroid cancer: The controversy remains. J Endocrinol
Invest. 40:891–892. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Moghoofei M, Mostafaei S, Nesaei A,
Etemadi A, Sadri Nahand J, Mirzaei H, Rashidi B, Babaei F and
Khodabandehlou N: Epstein-Barr virus and thyroid cancer: The role
of viral expressed proteins. J Cell Physiol. 234:3790–3799.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yu ST, Ge JN, Li RC, Wei ZG, Sun BH, Jiang
YM, Luo JY, Liu H and Lei ST: Is Epstein-Barr Virus infection
associated with thyroid tumorigenesis? a southern China cohort
study. Front Oncol. 9(312)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Guan Y, Jakimovski D, Ramanathan M,
Weinstock-Guttman B and Zivadinov R: The role of Epstein-Barr virus
in multiple sclerosis: From molecular pathophysiology to in vivo
imaging. Neural Regen Res. 14:373–386. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bar-Or A, Pender MP, Khanna R, Steinman L,
Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G and Joshi MA:
Epstein-Barr virus in multiple sclerosis: Theory and emerging
immunotherapies. Trends Mol Med. 26:296–310. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu MJ, Zhang Q, Liang L, Wang SY, Zheng
XC, Zhou MM, Yang YW, Zhong Q and Huang F: Association between
vitamin D deficiency and risk of thyroid cancer: A case-control
study and a meta-analysis. J Endocrinol Invest. 41:1199–1210.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim D: The role of vitamin D in thyroid
diseases. Int J Mol Sci. 18(1949)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sintzel MB, Rametta M and Reder AT:
Vitamin D and multiple sclerosis: A comprehensive review. Neurol
Ther. 7:59–85. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tomescu D, Cobilinschi C, Tincu RC, Totan
A, Neagu TP, Diaconu CC, Tiglis M, Bratu OG and Macovei RA: Changes
of thyroid hormonal status in organophosphate exposure. A
systematic literature review. Rev Chim. 69:3364–3366. 2018.
|
|
32
|
Marcu DR, Ionita Radu F, Iorga LD, Manea
M, Socea B, Scarneciu I, Isvoranu G, Costache R, Diaconu CC and
Bratu OG: Vascular involvement in primary retroperitoneal tumors.
Rev Chim. 70:445–448. 2019.
|
|
33
|
Marcu RD, Diaconu CC, Constantin T, Socea
B, Ionita-Radu F, Mischianu DL and Bratu OG: Minimally invasive
biopsy in retroperitoneal tumors. Exp Ther Med. 18:5016–5020.
2019.PubMed/NCBI View Article : Google Scholar : (Review).
|
|
34
|
Bratu OG, Diaconu CC, Mischianu DL,
Constantin T, Stanescu AM, Bungau SG, Ionita-Radu F and Marcu RD:
Therapeutic options in patients with biochemical recurrence after
radical prostatectomy. Exp Ther Med. 18:5021–5025. 2019.PubMed/NCBI View Article : Google Scholar
|
